Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors [Phase 1]
A Phase 1 clinical trial evaluating stereotactic body radiotherapy for treating primary renal cell carcinoma tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery [Phase 3]
Phase 3 trial evaluating sunitinib malate or sorafenib tosylate for kidney cancer post-surgery has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis [Phase 4]
Phase 4 clinical trial evaluating zoledronic acid in patients with renal cell carcinoma and bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies [Phase 2, Phase 3]
This clinical trial update reports results from a study of continued treatment with peginterferon alfa-2a or recombinant interferon alfa-2a …
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: Sunitinib Malate in Treating Patients With Kidney Cancer [NA]
The document reports the completion of a clinical trial evaluating sunitinib malate for kidney cancer (renal cell carcinoma). The snippet pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine [Phase 2]
Phase 2 study evaluating PD-1 inhibitor alone or with a dendritic cell/renal cell carcinoma fusion cell vaccine in renal cell carcinoma was …
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL) [Phase 1, Phase 2]
This document describes an early-phase dose-finding and safety/efficacy study of radium-223 dichloride (Xofigo) in patients with clear-cell …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)
This clinical trial update notes the completion of an observational study evaluating Avastin (bevacizumab) in combination with interferon al…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases [NA]
A pilot trial evaluating focal ablative stereotactic radiotherapy for cancers of the kidney and isolated adrenal metastases has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma [Phase 1]
A Phase 1 trial evaluating hydroxychloroquine administered before surgery in patients with renal cell carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma
A completed clinical trial update evaluates the optimal duration of tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma [Phase 1]
Phase 1 study evaluating the combination of bevacizumab with buparlisib (BKM-120) in patients with metastatic renal cell carcinoma has compl…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating sorafenib with or without recombinant interferon alfa-2b in patients with metastatic renal cell carcinoma; results …
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy [NA]
A completed clinical trial evaluating whether ulinastatin improves postoperative renal function in patients undergoing robot-assisted laparo…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus [Phase 2]
This Phase 2 trial examined biomarkers before and after nephrectomy in patients with locally advanced or metastatic renal cell carcinoma tre…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy [Phase 2]
A Phase 2 trial comparing GDC-0980 with Everolimus in patients with metastatic renal cell carcinoma who progressed after VEGF-targeted thera…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma [NA]
The clinical trial evaluating neo-adjuvant temsirolimus in patients with advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating matched unrelated donor transplant for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer [Phase 2]
Phase 2 trial evaluating 5-fluorouracil followed by interferon-alfa-2b in previously treated patients with metastatic gastrointestinal cance…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer
The document provides an update on a terminated clinical trial evaluating quality of life, fatigue, and cognitive function in anti-angiogeni…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial of capecitabine and gemcitabine in metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Bevacizumab in Metastatic Renal Cancer
A clinical trial evaluating bevacizumab in metastatic renal cell carcinoma has completed, and the results were posted in July 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) [Phase 3]
Phase 3 trial evaluating interferon alfa-2b with or without bevacizumab in advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
This clinical trial update notes termination of a Stanford-sponsored study evaluating C-arm CT during transarterial chemoembolization for he…